He started taking NeuroAiD™ two and a half months after having the brain stroke; the effects are amazing, as he has started walking and his right hand is also gaining back its mobility, and even more with the therapy that he is receiving, he is better, making progress every day
Javier Torres (Peru)
Information for Medical Professionals
Learn key facts about NeuroAiD and assess how it can be relevant in your clinical practices
NeuroAiD™ is a trademark of Moleac. MLC601 (NeuroAiD™) and MLC901 (NeuroAiD™II / NurAiD™II) are 2 different proprietary formulae which have been shown to be equivalent in pharmacology and are referred as «NeuroAiD» on this page, except in case of specific mentions.